4D Molecular Therapeutics, Inc.(FDMT)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
FDMT | 723.7 M | - | 25106.70% | -194.74% | -$2.60 | -43.25% | 0.10x | 0.00% | $16.93 | $6.96 |
VRTX | 130.44 B | 29.80x | 12.50% | 35.00% | $17.27 | 23.54% | 0.10x | 0.00% | $560.25 | $403.16 |
MRNA | 96.65 B | - | 2.10% | -141.43% | -$7.98 | -39.00% | 0.19x | 0.00% | $242.29 | $22.28 |
REGN | 81.67 B | 19.97x | 16.70% | 27.87% | $40.44 | 14.04% | 0.09x | 0.46% | $859.34 | $563.22 |
TECH | 11.38 B | 62.57x | 1.30% | 14.97% | $1.16 | 9.03% | 0.14x | 0.44% | $72.69 | $43.07 |
IONS | 7.54 B | - | -40.70% | -64.66% | -$3.48 | -105.50% | 4.98x | 0.00% | $86.74 | $42.08 |
Peer Valuation & Performance Analysis
Peer group analysis for 4D Molecular Therapeutics, Inc. (FDMT) compared to its primary competitors (including VRTX, MRNA, REGN) reveals distinct metrics. FDMT trades at a valuation discount relative to its competitors, with a P/E ratio of -5.0x versus the peer average of 10.9x (representing a 146% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, FDMT's revenue growth of 25106.7% exceeds the peer average of -11.4%, highlighting its competitive strength and market share gains. Additionally, its net margin of -194.7% is below the peer average of -21.4%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• FDMT ranks #0 in P/E ratio, #1 in revenue growth, and #5 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $12.29 | $13.39 | $12.29 | $13.10 | 718,020 | +6.59% |
| 2026-10-19 | $12.36 | $12.68 | $12.21 | $12.29 | 855,700 | +1.24% |
| 2026-10-16 | $12.84 | $12.84 | $12.00 | $12.14 | 794,500 | -5.67% |
| 2026-10-15 | $12.30 | $13.01 | $12.04 | $12.87 | 787,600 | +5.49% |
| 2026-10-14 | $12.18 | $12.58 | $11.99 | $12.20 | 633,000 | -1.29% |
| 2026-10-13 | $12.91 | $12.91 | $12.25 | $12.36 | 991,700 | -4.92% |
| 2026-10-12 | $13.30 | $13.47 | $12.86 | $13.00 | 835,800 | -2.48% |
| 2026-10-09 | $12.70 | $13.85 | $12.55 | $13.33 | 867,900 | +4.96% |
| 2026-10-08 | $12.42 | $12.73 | $12.12 | $12.70 | 970,800 | +0.87% |
| 2026-10-07 | $12.36 | $12.92 | $12.19 | $12.59 | 603,600 | +0.24% |
| 2026-10-06 | $12.64 | $13.02 | $12.30 | $12.56 | 1,170,900 | -2.79% |
| 2026-10-05 | $13.86 | $13.86 | $12.61 | $12.92 | 2,110,300 | -5.49% |
| 2026-10-02 | $14.12 | $14.13 | $13.60 | $13.67 | 1,036,900 | -1.23% |
| 2026-10-01 | $14.23 | $14.58 | $13.80 | $13.84 | 655,500 | -3.28% |
| 2026-09-30 | $14.76 | $14.83 | $14.07 | $14.31 | 1,037,100 | -1.24% |
Explore More Analysis for FDMT
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.